2018-09-15： Research and Development of Innovative New Advanced TCMP

News from China SXT: Dr. Jingzhen Deng, the Chief Executive Officer and Chief Scientific Officer of Jiangsu SXT Pharmaceutical Co., Ltd., was invited for giving a special talk about “Researc......

Nasdaq’s Head of Healthcare Listings Shares 2018 Predictions for Biotech IPOs

Nasdaq: What is the current market environment for biotech initial public offerings and biotech listings overall?Saxe: I expect that 2018 will demonstrate positive momentum for biotech listings o......

2018-03-08：Dr. Jingzhen Deng Invited on the Special Speech “Currently, the Research and Development Trend Discussion on Traditional Chinese Medicine”

News from China SXT: Dr. Jingzhen Deng, the Chief Scientific Officer of our company, was invited for giving a special talk about“Currently, the Research and Development Trend Discussion......

ABOUT US COMPANY PROFILE MANAGEMENT COMPANY STRUCTURE COMPANY NEWS HIRING CONTACT US COMPANY NEWS首页 > COMPANY NEWS 2018-01-23：Dr. Jingzhen Deng Invited to Speak at the Upcoming “4th World Congress and

Dear Dr. Jing-Zhen Deng,Greeting from Antibiotics 2018!!It is my sincere pleasure to invite you to speak at the upcoming "4th World Congress and Exhibition on Antibiotics and Antib......

2017-11-06：Dr. Jingzhen Deng Invited to Make the Special Speech “Conception and R&D about Innovative TCM”

News from China SXT: On Nov 4-5, 2017, our company COO and CSO, Dr. Jingzhen Deng, invited to attend the “National R&D Key Technology Forum about Classic TCPM and Non-clinical TCM”&......